Article | REF: P1098 V2

Polymorphism. Basic principles and characterization methods

Author: Michel BAUER

Publication date: November 10, 2022 | Lire en français

You do not have access to this resource.
Click here to request your free trial access!

Already subscribed? Log in!

Automatically translated using artificial intelligence technology (Note that only the original version is binding) > find out more.

    A  |  A

    2. Some regulatory aspects of the pharmaceutical sector

    The need to study the polymorphism and physical properties of active ingredients and excipients has long been recognized by the health authorities issuing marketing authorizations. However, the "guidelines" were not at all detailed as to how to set up a study strategy and define quality standards for both the active ingredient and the finished product. To the best of our knowledge, one of the first articles on this subject was by Byrn et al. ...

    You do not have access to this resource.

    Exclusive to subscribers. 97% yet to be discovered!

    You do not have access to this resource.
    Click here to request your free trial access!

    Already subscribed? Log in!


    The Ultimate Scientific and Technical Reference

    A Comprehensive Knowledge Base, with over 1,200 authors and 100 scientific advisors
    + More than 10,000 articles and 1,000 how-to sheets, over 800 new or updated articles every year
    From design to prototyping, right through to industrialization, the reference for securing the development of your industrial projects

    This article is included in

    Drugs and pharmaceuticals

    This offer includes:

    Knowledge Base

    Updated and enriched with articles validated by our scientific committees

    Services

    A set of exclusive tools to complement the resources

    Practical Path

    Operational and didactic, to guarantee the acquisition of transversal skills

    Doc & Quiz

    Interactive articles with quizzes, for constructive reading

    Subscribe now!

    Ongoing reading
    Some regulatory aspects of the pharmaceutical sector